Daptomycin underexposure in a young intravenous drug user who was affected by life-threatening Staphylococcus aureus-complicated skin and soft tissue infection associated with bacteraemia
INFECTION (2014)
期刊
INFECTION
卷 42, 期 1, 页码 207-210出版社
SPRINGER HEIDELBERG
关键词
作者
我是这篇论文的作者
推荐
The impact of daptomycin therapeutic drug monitoring on clinical outcomes: a systematic review
Kelly A. Cairns, Iain J. Abbott, Michael J. Dooley, Anton Y. Peleg, Trisha N. Peel, Andrew A. Udy
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)
Potential benefits of therapeutic drug monitoring for beta-lactam antibiotics in augmented renal clearance patients: a case report
Ibrahim El-Haffaf, Jean Laverdiere, Martin Albert, Amelie Marsot, David Williamson
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2023)
Implementation and Comparison of Two Pharmacometric Tools for Model-Based Therapeutic Drug Monitoring and Precision Dosing of Daptomycin
Justine Heitzmann, Yann Thoma, Romain Bricca, Marie-Claude Gagnieu, Vincent Leclerc, Sandrine Roux, Anne Conrad, Tristan Ferry, Sylvain Goutelle
PHARMACEUTICS (2022)
Impact on Antibiotic Resistance, Therapeutic Success, and Control of Side Effects in Therapeutic Drug Monitoring (TDM) of Daptomycin: A Scoping Review
Carolina Osorio, Laura Garzon, Diego Jaimes, Edwin Silva, Rosa-Helena Bustos
ANTIBIOTICS-BASEL (2021)
Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review
Jitka Rychlickova, Vendula Kubickova, Pavel Suk, Karel Urbanek
ANTIBIOTICS-BASEL (2023)
Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapy
William A. Clarke, Etienne Chatelut, Alan K. Fotoohi, Richard A. Larson, Jennifer H. Martin, Ron H. J. Mathijssen, Salvatore J. Salamone
EUROPEAN JOURNAL OF CANCER (2021)
First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection
Edward J. Gane, Won Kim, Tien Huey Lim, Pisit Tangkijvanich, Jung-Hwan Yoon, William Sievert, Wattana Sukeepaisarnjaroen, Alexander J. Thompson, Vedran Pavlovic, Bernadette Surujbally, Cynthia Wat, Bob D. Brown, Hardean E. Achneck, Man-Fung Yuen
JOURNAL OF HEPATOLOGY (2023)
Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel disease
Debbie S. Deben, Dennis R. Wong, Adriaan A. van Bodegraven
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
Use of therapeutic drug monitoring to characterize cefepime-related neurotoxicity
Veena Venugopalan, Danielle Casaus, Leonie Kainz, Cara N. Slaton, Natalie Hurst, Maria Bruzzone, Calvin Hu, Gabriel Sword, Kartikeya Cherabuddi, Nicole Iovine, Jiajun Liu, Marc H. Scheetz, Nathaniel Rhodes, Nicole Maranchick, Charles A. Peloquin, Kenneth Klinker, Mohammad H. Alshaer
PHARMACOTHERAPY (2023)
Automated Interlaboratory Comparison of Therapeutic Drug Monitoring Data and Its Use for Evaluation of Published Therapeutic Reference Ranges
Jens Borggaard Larsen, Elke Hoffmann-Lucke, Per Hersom Aaslo, Niklas Rye Jorgensen, Eva Greibe
PHARMACEUTICS (2023)
Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?
Daniela Baracaldo-Santamaria, Juan David Cala-Garcia, German Jose Medina-Rincon, Luis Carlos Rojas-Rodriguez, Carlos-Alberto Calderon-Ospina
ANTIBIOTICS-BASEL (2022)
Immunosuppressant quantification in intravenous microdialysate - towards novel quasi-continuous therapeutic drug monitoring in transplanted patients
Susanne Weber, Sara Tombelli, Ambra Giannetti, Cosimo Trono, Mark O'Connell, Ming Wen, Ana B. Descalzo, Heike Bittersohl, Andreas Bietenbeck, Pierre Marquet, Lutz Renders, Guillermo Orellana, Francesco Baldini, Peter B. Luppa
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Association between vancomycin therapeutic drug monitoring and clinical outcomes in treating neonatal sepsis
Erin Chung, Winnie Seto
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)
Clinical Response and Hospital Costs of Therapeutic Drug Monitoring for Vancomycin in Elderly Patients
Yun Kim, Soohyun Kim, Jinsook Park, Howard Lee
JOURNAL OF PERSONALIZED MEDICINE (2022)
Immunosuppressant quantification in intravenous microdialysate - towards novel quasi-continuous therapeutic drug monitoring in transplanted patients
Susanne Weber, Sara Tombelli, Ambra Giannetti, Cosimo Trono, Mark O'Connell, Ming Wen, Ana B. Descalzo, Heike Bittersohl, Andreas Bietenbeck, Pierre Marquet, Lutz Renders, Guillermo Orellana, Francesco Baldini, Peter B. Luppa
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Clinical efficacy of renal dosing adjustments of ceftazidime-avibactam in patients affected by carbapenem-resistant Gram-negative infections: A systematic review and meta-analysis of observational studies
Milo Gatti, Giacomo Fornaro, Pierluigi Viale, Federico Pea, Maddalena Giannella
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams
Milo Gatti, Federico Pea
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2023)
Fast and Simple Liquid Chromatography-Isotope Dilution Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Dalbavancin in Long-Term Treatment of Subacute and/or Chronic Infections
Rossella Barone, Matteo Conti, Pier Giorgio Cojutti, Milo Gatti, Pierluigi Viale, Federico Pea
PHARMACEUTICS (2023)
Targeted Therapy of Severe Infections Caused by Staphylococcus aureus in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World Evidence
Milo Gatti, Bruno Viaggi, Gian Maria Rossolini, Federico Pea, Pierluigi Viale
MICROORGANISMS (2023)
Fast and Sensitive Analysis of Cefiderocol in Human Plasma Microsamples by Liquid Chromatography-Isotope Dilution Tandem Mass Spectrometry for Therapeutic Drug Monitoring
Rossella Barone, Matteo Conti, Pier Giorgio Cojutti, Milo Gatti, Pierluigi Viale, Federico Pea
ANTIBIOTICS-BASEL (2023)
Population Pharmacokinetic and Pharmacodynamic Analysis of Valganciclovir for Optimizing Preemptive Therapy of Cytomegalovirus Infections in Kidney Transplant Recipients
Pier Giorgio Cojutti, Aaron J. Heffernan, Thomas Tangden, Paola Della Siega, Carlo Tascini, Jason A. Roberts, Federico Pea
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin
Alessandra Oliva, Sergio Carbonara, Vito Cianci, Massimo Crapis, Enea Gino Di Domenico, Marco Falcone, Gioacchino Galardo, Emanuele Durante-Mangoni, Mario Venditti
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2023)
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections
Milo Gatti, Vincent H. Tam, Paolo Gaibani, Pier Giorgio Cojutti, Pierluigi Viale, Federico Pea
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections
Milo Gatti, Pierluigi Viale, Pier Giorgio Cojutti, Eleonora Zamparini, Massimiliano De Paolis, Maddalena Giannella, Federico Pea, Sara Tedeschi
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)
Comment on: pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections
Milo Gatti, Federico Pea
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?
Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, Paolo Gaibani, Maddalena Giannella, Pierluigi Viale, Federico Pea
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)
Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin
Alessandra Oliva, Francesco Giuseppe De Rosa, Malgorzata Mikulska, Federico Pea, Maurizio Sanguinetti, Carlo Tascini, Mario Venditti
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2023)
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia
Milo Gatti, Matteo Rinaldi, Paolo Gaibani, Antonio Siniscalchi, Tommaso Tonetti, Pierluigi Viale, Federico Pea
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)
Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections
Pasquale Maria Berrino, Milo Gatti, Matteo Rinaldi, Eugenio Brunocilla, Pierluigi Viale, Federico Pea
ANTIBIOTICS-BASEL (2023)
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections
Altea Gallerani, Milo Gatti, Andrea Bedini, Stefania Casolari, Gabriella Orlando, Cinzia Puzzolante, Erica Franceschini, Marianna Menozzi, Antonella Santoro, Nicole Barp, Sara Volpi, Alessandra Soffritti, Federico Pea, Cristina Mussini, Marianna Meschiari
ANTIBIOTICS-BASEL (2023)